| 1 |
35402005 | The Relation of Haplotype ATP-binding Cassette B1 and Glutathione S-transferase P1 A313G Genes with Hematological Toxicity in Indonesian Breast Cancer Patients Receiving Chemotherapy. | 2022 Mar |
2 |
| 2 |
35456712 | Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia. | 2022 Apr 17 |
1 |
| 3 |
35462331 | ABCB1 as a potential beneficial target of midostaurin in acute myeloid leukemia. | 2022 Jun |
2 |
| 4 |
34126072 | CMP25, a synthetic new agent, targets multidrug resistance-associated protein 7 (MRP7/ABCC10). | 2021 Aug |
1 |
| 5 |
32158919 | Dynamic induction of drug resistance through a stress-responsive enhancer in acute myeloid leukemia. | 2020 |
1 |
| 6 |
32430093 | Pivarubicin Is More Effective Than Doxorubicin Against Triple-Negative Breast Cancer In Vivo. | 2020 Dec 10 |
1 |
| 7 |
29090664 | Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia. | 2018 |
1 |
| 8 |
30538383 | P-Glycoprotein Expression in Indian Breast Cancer Patients with Reference to Molecular Subtypes and Response to Anthracycline-Based Chemotherapy-a Prospective Clinical Study from a Developing Country. | 2018 Dec |
1 |
| 9 |
28763429 | Genome-wide association study of cardiotoxicity in the NCCTG N9831 (Alliance) adjuvant trastuzumab trial. | 2017 Oct |
1 |
| 10 |
29145976 | Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins. | 2017 May |
4 |
| 11 |
29162041 | Does anthracycline-based chemotherapy in pregnant women with cancer offer safe cardiac and neurodevelopmental outcomes for the developing fetus? | 2017 Nov 21 |
2 |
| 12 |
26799497 | Evidence for association of SNPs in ABCB1 and CBR3, but not RAC2, NCF4, SLC28A3 or TOP2B, with chronic cardiotoxicity in a cohort of breast cancer patients treated with anthracyclines. | 2016 Feb |
1 |
| 13 |
27545834 | Increased proapoptotic activity of electron beam irradiated doxorubicin and epirubicin in multidrug-resistant human leukemic cells. | 2016 Oct 25 |
1 |
| 14 |
27725879 | Targeting ABCB1-mediated tumor multidrug resistance by CRISPR/Cas9-based genome editing. | 2016 |
2 |
| 15 |
27795507 | Progress in the treatment of mature T-cell lymphoma. | 2016 |
1 |
| 16 |
24678978 | The role of P-glycoprotein in drug resistance in multiple myeloma. | 2015 Jan |
1 |
| 17 |
25567217 | Association of ABCB1 polymorphisms with prognostic outcomes of anthracycline and cytarabine in Chinese patients with acute myeloid leukemia. | 2015 Mar |
1 |
| 18 |
25685543 | P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review. | 2015 Jan |
1 |
| 19 |
25788263 | Cbl-b inhibits P-gp transporter function by preventing its translocation into caveolae in multiple drug-resistant gastric and breast cancers. | 2015 Mar 30 |
1 |
| 20 |
24574923 | The connection between the toxicity of anthracyclines and their ability to modulate the P-glycoprotein-mediated transport in A549, HepG2, and MCF-7 cells. | 2014 |
1 |
| 21 |
23707158 | Influence of ABCB1 genetic variants in breast cancer treatment outcomes. | 2013 Oct |
1 |
| 22 |
23768637 | Epstein-Barr virus-associated natural killer/T-cell lymphomas. | 2013 Mar |
1 |
| 23 |
21374643 | Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression. | 2012 Nov |
2 |
| 24 |
22158944 | Nanocarriers enhance Doxorubicin uptake in drug-resistant ovarian cancer cells. | 2012 Feb 1 |
2 |
| 25 |
22310978 | Polymorphisms in genes involved in drug detoxification and clinical outcomes of anthracycline-based neoadjuvant chemotherapy in Chinese Han breast cancer patients. | 2012 Mar |
1 |
| 26 |
22986993 | Twist confers chemoresistance to anthracyclines in bladder cancer through upregulating P-glycoprotein. | 2012 |
5 |
| 27 |
20944122 | Caveolin-1 and doxorubicin-induced P-glycoprotein modulate plasma cholesterol membrane accessibility in erythrolymphoblastic cell line. | 2010 Sep |
1 |
| 28 |
19440163 | Induction of 1C aldoketoreductases and other drug dose-dependent genes upon acquisition of anthracycline resistance. | 2009 Jun |
1 |
| 29 |
19470292 | Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy. | 2009 |
1 |
| 30 |
19088019 | Pharmacogenetics in breast cancer therapy. | 2008 Dec 15 |
1 |
| 31 |
19129072 | Role of ABCB1 and ABCC1 gene induction on survival in locally advanced breast cancer. | 2008 Dec |
1 |
| 32 |
19151448 | Polymorphism C3435T of the MDR-1 gene predict response to preoperative chemotherapy in locally advanced breast cancer with Her2/neu expression. | 2008 Oct |
2 |
| 33 |
16642371 | A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer. | 2007 Jan |
2 |
| 34 |
17256837 | Isomeric N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent P-glycoprotein (Pgp)-dependent multidrug resistance (MDR) inhibitors. | 2007 Feb 22 |
1 |
| 35 |
17483874 | A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance. | 2007 Aug |
1 |
| 36 |
17620438 | Inhibition of the mitogen-activated protein kinase pathway results in the down-regulation of P-glycoprotein. | 2007 Jul |
4 |
| 37 |
16001170 | Effect of amifostine on the cytotoxicity of daunorubicin and daunoxome in tumor and normal cells. | 2006 Apr |
2 |
| 38 |
16451059 | Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance. | 2006 Feb 9 |
6 |
| 39 |
16521213 | Relationship between therapeutic efficacy of arterial infusion chemotherapy and expression of P-glycoprotein and p53 protein in advanced hepatocellular carcinoma. | 2006 Feb 14 |
1 |
| 40 |
16842217 | Pharmacological strategies for overcoming multidrug resistance. | 2006 Jul |
1 |
| 41 |
18528466 | The individualization of cancer therapy: the unexpected role of p53. | 2006 |
2 |
| 42 |
23506066 | Anthracyclines as effective anticancer drugs. | 2006 Nov |
2 |
| 43 |
15703814 | Y-box binding protein, YB-1, as a marker of tumor aggressiveness and response to adjuvant chemotherapy in breast cancer. | 2005 Mar |
1 |
| 44 |
15963852 | RNAi-mediated knockdown of P-glycoprotein using a transposon-based vector system durably restores imatinib sensitivity in imatinib-resistant CML cell lines. | 2005 Jul |
2 |
| 45 |
16159384 | Anthracyclines, proteasome activity and multi-drug-resistance. | 2005 Sep 13 |
1 |
| 46 |
15457126 | Ex vivo reversal of chemoresistance by tariquidar (XR9576). | 2004 Oct |
2 |
| 47 |
12542697 | New insights into the P-glycoprotein-mediated effluxes of rhodamines. | 2003 Feb |
2 |
| 48 |
12914384 | Pharmacogenetics of stomach cancer. | 2003 Sep-Oct |
1 |
| 49 |
14499178 | N-methylation of anthracyclines modulates their cytotoxicity and pharmacokinetic in wild type and multidrug resistant cells. | 2003 Sep |
2 |
| 50 |
14981994 | Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: case report and review of the literature. | 2003 Nov-Dec |
1 |